what glp 1 does noom offer Med Noom GLP-1 Review 2026: Great

Vila Petroff MG, Egan JM, Wang X, Sollott SJ

For an obese patient, prescribers may have to justify why lifestyle/diet alone is insufficient

GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)

Focus on lean proteins, vegetables, whole grains, and healthy fats, and avoid processed foods and added sugar

The source and quality of tirzepatide matters more than many people realize